Article
Suppressed oncogenic molecules involved in the treatment of colorectal cancer by fecal microbiota transplantation
13 Nov 2024
Abstract excerpt
Dysbiosis of the intestinal microbiota is prevalent among patients with colorectal cancer (CRC). This study aims to explore the anticancer roles of the fecal microbiota in inhibiting the progression of colorectal cancer and possible mechanisms. The intestinal microbial dysbiosis in CRC mice was significantly ameliorated by fecal microbiota transplantation (FMT), as indicated by the restored ACE index and Shannon...
Topics
Join the communities discussing this publication.